TD Cowen analyst Charles Rhyee lowered the firm’s price target on Icon (ICLR) to $183 from $209 and keeps a Hold rating on the shares. The firm said although the demand environment for CRO has stabilized they do not believe consensus fully reflects the impact of lower-than-normal B2Bs in 1H25, likely to persist into 2H25, on 2026 revenue and adjusted EBITDA growth.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ICLR:
- Icon management to meet with Mizuho
- Lululemon downgraded, Dick’s Sporting upgraded: Wall Street’s top analyst calls
- Icon downgraded to Hold from Buy at Jefferies
- Buy Rating Affirmed for Icon Amid CEO Transition and Market Challenges
- ICON Plc and Zealand Pharma’s Petrelintide Study: A Key Update for Investors